WeVote
Log In

Bill

Bill

SB 1230

marijuana; clinical research trials

57th Legislature - First Regular Session Introduced by Kevin Payne

Arizona bill permits regulated marijuana use in federally-approved clinical research trials to advance medical knowledge of cannabis's therapeutic effects.

PASSED
0
WeVote Research Nonpartisan
Bill Summary · SB 1230

Legislative bill overview

SB 1230 establishes a framework for clinical research trials involving marijuana in Arizona, allowing state-regulated cannabis to be used in federally-approved medical studies. The bill creates mechanisms for researchers to access marijuana products for legitimate clinical investigations while maintaining compliance with both state and federal regulations.

Why is this important

This legislation addresses a significant gap in medical research by enabling scientists to study marijuana's therapeutic potential in controlled settings, which has been limited by federal scheduling. Expanding clinical research could generate evidence-based data on cannabis effectiveness for various conditions, informing future medical policy and patient treatment options.

Potential points of contention

  • Federal-state conflict: Marijuana remains a Schedule I substance federally, creating legal ambiguity and potential complications for researchers and institutions receiving federal funding
  • Research access and equity: Determining which research institutions qualify and how to ensure equitable access to study subjects across different populations
  • Product quality and standardization: Establishing consistent testing, dosing, and documentation standards for cannabis products used in clinical trials to ensure research validity

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.